In comparative analysis, EchoGo® Amyloidosis outperformed two validated clinical scoring systems, the Transthyretin Cardiac ...

Among 3,727 consecutive patients with HF and LVEF of 50% or more, 8.3% had a clinician-assigned diagnosis of HFpEF, despite AI analysis demonstrating that as many as 75.4% met ESC diagnostic ...

Despite these clear criteria, diagnosis remains a challenge and is often made after excluding noncardiac causes. HFpEF affects an elderly patient population burdened by multiple comorbid conditions.

Those who met the entry criteria were randomized to treatment with dapagliflozin 10 mg once daily or placebo for 24 weeks. ... “Remarkably, one-third of patients treated with dapagliflozin no longer ...

Ultromics, a pioneer in AI-driven cardiology solutions, has unveiled the latest enhancement to EchoGo® Heart Failure: the introduction of a first-of-its-kind AI-powered probability scoring system ...

In a world-first randomized study, catheter ablation has been shown to reverse heart failure with preserved ejection fraction (HFpEF) in patients with both HFpEF and atrial fibrillation (AF).

According to the CDC, 40.3% of US adults meet criteria for obesity, and rising numbers are in ranges of severe obesity. 2 Rates are higher among adults aged 40 to 59 years than among young adults ...

Eli Lilly and Company (NYSE: LLY) today announced detailed results from the SUMMIT Phase 3 trial showing tirzepatide significantly reduced the risk of worsening heart failure events in adults with ...

OXFORD, England, Aug. 2, 2023 /PRNewswire/ -- Ultromics, a pioneer in advancing heart failure diagnostics through artificial intelligence (AI), has received approval for NTAP from the Centers for ...